ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ALK-Abello AS (ALK B) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9871
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It markets diagnostics and other services to allergy clinics. The company’s allergy immunotherapy product portfolio includes tablet-based vaccines, sublingual or drop-based vaccines, subcutaneous vaccines; and adrenaline auto-injector to treat severe allergic reactions in emergencies (anaphylaxis). ALK’s research and development pipeline products include sublingual immunotherapy tablets for addressing the ragweed, house dust mite and tree pollen allergy. The company’s products target allergies caused by grass, tree, ragweed, house dust mite, Japanese cedar, dog, venom and cat, among others. It has subsidiaries in Europe, North America, Asia-Pacific and other international markets. ALK is headquartered in Horsholm, Denmark.

ALK-Abello AS (ALK B) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ALK-Abello AS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Alk Abello Enters into Co-Marketing Agreement with BioCSL 11
ALK-Abello Enters into Agreement with Seqirus 12
ALK-Abello Expands Partnership with Abbott Labs 13
ALK-Abello Enters Into Co-Marketing Agreement With Eddingpharm 14
ALK Enters Into Co-Promotion Agreement With MSD For Grazax 15
Licensing Agreements 16
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 16
Equity Offering 17
ALK-Abello Raises USD10.2 Million in Private Placement of AA Shares 17
ALK-Abello Raises USD101.5 Million in Private Placement of B Shares 18
Center Labs to Raise USD96 Million in Private Placement of Shares 19
Center Labs to Raise Funds through Private Placement of Shares 20
ALK-Abello AS – Key Competitors 21
ALK-Abello AS – Key Employees 22
ALK-Abello AS – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Aug 15, 2018: ALK-Abello: Six-month interim report (Q2) 2018 25
May 04, 2018: ALK Releases Three-month interim report (Q1) 2018 26
Feb 06, 2018: ALK releases its annual report 2017 27
Nov 10, 2017: ALK-Abello: Nine-month interim report (Q3) 2017 28
Aug 16, 2017: ALK-Abello: Six-month interim report (Q2) 2017 29
Aug 16, 2017: ALK: Six-month interim report (Q2) 2017 30
May 09, 2017: ALK-Abello Announces Three-month interim report (Q1) 2017 31
Feb 07, 2017: ALK releases its annual report 2016 32
Corporate Communications 33
Nov 03, 2017: ALK appoints Soren Jelert as new Chief Financial Officer 33
Jul 31, 2017: Management change at ALK 34
Mar 03, 2017: ALK Appoints SVP of R&D for North America and International Markets 35
Jan 10, 2017: Carsten Hellmann joins ALK as new President and CEO 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ALK-Abello AS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Alk Abello Enters into Co-Marketing Agreement with BioCSL 11
ALK-Abello Enters into Agreement with Seqirus 12
ALK-Abello Expands Partnership with Abbott Labs 13
ALK-Abello Enters Into Co-Marketing Agreement With Eddingpharm 14
ALK Enters Into Co-Promotion Agreement With MSD For Grazax 15
Japan Tobacco, Torii Pharmac Enter into Licensing Agreement with ALK-Abello 16
ALK-Abello Raises USD10.2 Million in Private Placement of AA Shares 17
ALK-Abello Raises USD101.5 Million in Private Placement of B Shares 18
Center Labs to Raise USD96 Million in Private Placement of Shares 19
Center Labs to Raise Funds through Private Placement of Shares 20
ALK-Abello AS, Key Competitors 21
ALK-Abello AS, Key Employees 22
ALK-Abello AS, Subsidiaries 23

List of Figures
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ALK-Abello AS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Tenaga Nasional Bhd (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Bhd (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Parion Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Parion Sciences Inc (Parion Sciences) is a development stage company that provides research, development and commercialization of treatments to improve patient’s innate mucosal surface defenses. The company’s pipeline products include P-1037, a clinical stage ENaC blocker for pulmonary disea …
  • GMR Infrastructure Limited (GMRINFRA)-エネルギー分野:企業M&A・提携分析
    Summary GMR Infrastructure Limited (GMR), a subsidiary of GMR Enterprises Private Limited, is a holding company which undertakes various projects across airport, energy, transportation and urban infrastructure sectors. The company owns and operates Delhi's Indira Gandhi International Airport, Rajiv …
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HRG Group, Inc. (HRG)-石油・ガス分野:企業M&A・提携分析
    Summary HRG Group, Inc. (HRG), formerly, Harbinger Group Inc., is a diversified investment holding company, with interests in various businesses such as branded consumer products, which include consumer batteries, residential locksets, faucets, shaving and grooming products, personal care products, …
  • Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ):製薬・医療:M&Aディール及び事業提携情報
    Summary Eckert & Ziegler Strahlen- und Medizintechnik AG (Eckert & Ziegler) is a medical device company that offers isotope technology products. The company offers radiation therapy, isotope and radio-pharma products. It provides radiation therapy products for Brachytherapy, a minimally invasive pro …
  • Bharat Heavy Electricals Ltd (BHEL)-エネルギー分野:企業M&A・提携分析
    Summary Bharat Heavy Electricals Limited (BHEL) is an integrated power plant equipment manufacturer that designs, manufactures, constructs, tests, commissions and services a broad range of products. Its product portfolio includes transformers, valves and oil field equipment, electrostatic precipitat …
  • Visaka Industries Ltd:企業の戦略・SWOT・財務情報
    Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fluor Corporation (FLR)-石油・ガス分野:企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a global provider of engineering and construction services. Its service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. It also offers other services …
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sime Darby Berhad:企業の戦略・SWOT・財務情報
    Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Senior Plc:企業の戦略・SWOT・財務情報
    Senior Plc - Strategy, SWOT and Corporate Finance Report Summary Senior Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Arrowhead Pharmaceuticals Inc (ARWR):企業の財務・戦略的SWOT分析
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly known as Arrowhead Research Corp, is a pharmaceutical company. It develops and markets medicinal products including ARO-AAT, JNJ-3989, ARO-APOC3, ARO-ANG3, ARO-ENaC, ARO-HIF2, ARO-Lung2, ARO-HSD, ARO-HIF2, AMG 890, ARO-JNJ1, ARO-JNJ2 and AR …
  • British Columbia Investment Management Corp:企業の戦略的SWOT分析
    British Columbia Investment Management Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Empresa Nacional del Petroleo:電力:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Jakks Pacific, Inc.:企業の戦略・SWOT・財務分析
    Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report Summary Jakks Pacific, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野:企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …
  • TerraForm Power Inc (TERP):電力:M&Aディール及び事業提携情報
    Summary TerraForm Power Inc (TerraForm Power), formerly SunEdison Yieldco Inc, a subsidiary of Brookfield Asset Management Inc, is an energy development company that owns and operates energy power plants. The company generates and distributes renewable energy by utilizing various clean power generat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆